Posted On: February 23, 2012 by Farah & Farah

Counterfeit Cancer Drug Circulates in United States

The U.S. Food and Drug Administration (FDA) is investigating how fake vials of the widely used cancer drug Avastin found their way to 19 doctors and clinics in the United States — raising alarms that the large, and growing, multi-billion worldwide drug-counterfeiting trade is making further inroads into America.

Reuters reported that the trail of the fake Avastin led back to an Egyptian company called SAWA. Hadicon, the Swiss-based import/export company that purchased the fake drug from SAWA, provided an address for the company that was located in Giza, a suburb of Cairo. However, reporters who went to the location revealed that no such company existed and locals had never heard of it. Egyptian authorities say the company is not registered with the Egyptian Health Ministry either.

Hadicon, which claims it was unaware that it was exporting a phony drug, sold to a British company, which in turn exported it to a Tennessee-based wholesaler called Volunteer Distribution.


This latest bogus drug scare, along with past incidents of counterfeited Viagra, Lipitor, and Alli that have hit the U.S. market, highlights the growing complexity and dangers of the worldwide drug supply-chain. Drugs and drug ingredients sold in the U.S. are increasingly being manufactured overseas in countries with spotty regulations and poor oversight.

Last year 1,700 cases of drug counterfeiting were reported worldwide. The U.S. accounted for six percent of those cases.

Fake Drug Dangers

With more drugs and drug ingredients being imported from overseas, it is becoming clear that stricter oversight of imported drugs and drug ingredients is sorely needed. Fake drugs are not only illegal, but also potentially deadly. If any drug has harmed you, you have legal recourse to obtain compensation for your injuries. Call the Florida dangerous drugs lawyers at Farah & Farah for a free and private consultation. We’re available day or night at (800) 533-3555.

Sources http://www.reuters.com/article/2012/02/21/avastin-egypt-idUSL5E8DL8R020120221;http://www.fda.gov/Drugs/DrugSafety/ucm291960.htm?utm_source=fda&utm_medium=website&utm_term=Aspirin&utm_content=f1&utm_campaign=HomePageSpotlight